$497M IDIQ Announced for Navy Medicine R&D; SAIC, GDIT, Booz Allen Win Spots

The U.S. Army has announced a $497 million Omnibus III indefinite-delivery/indefinite-quantity contract to support U.S. Navy medicine research and development programs.

The following firms were awarded positions on the award:

Contract work will support the Navy’s mission to conduct R&D across its medical enterprise. This includes commands that the Navy reports to or supports, such as OASD-Health Affairs and JTF CapMed.

Awardees will provide personnel, materials, equipment and process infrastructure, which includes vaccine development, clinical trials and application processing.

There were 32 bids solicited, with 32 bids received. Work is expected to be completed Aug. 11, 2016.

The U. S. Army ACC-APG, Natick Contracting Division awarded the IDIQ to support Navy medicine.

You may also be interested in...


Fluor Subsidiary Gets $1.1B Modification on US Naval Nuclear Propulsion Support Contract

A subsidiary of Fluor (NYSE: FLR) will continue its support work on propulsion systems that power U.S. Navy submarines and aircraft carriers under a one-year, $1.12B contract modification. Fluor Marine Propulsion will continue services at the Naval Nuclear Laboratory through the government's 2021 fiscal year, the Department of Defense said Wednesday.

Mac Curtis Chairman and CEO Perspecta

Perspecta Announced as Military Bowl Presenting Sponsor; Mac Curtis Quoted

The Military Bowl Foundation has named Perspecta (NYSE: PRSP) as the presenting sponsor for the next three years of its college football post-season bowl game.